|
2024
|
Invention
|
Methods of treating a cognitive impairment. The disclosure pertains to treating a cognitive impai... |
|
|
Invention
|
Blood plasma fractions for use in muscle regeneration.
Methods and compositions for treating agi... |
|
|
Invention
|
Blood plasma fractions for use in liver regeneration.
Methods and compositions for treating agin... |
|
|
Invention
|
Compositions of blood plasma fractions and blood plasma subfractions and their use in treatment o... |
|
|
Invention
|
Blood plasma fractions as a treatment for chemotherapy induced cognitive disorders. Methods and c... |
|
|
Invention
|
Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging... |
|
2023
|
Invention
|
Blood plasma fractions for improvement of myelination. Methods and compositions for restoring mye... |
|
|
Invention
|
Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative reco... |
|
|
Invention
|
Methods and compositions for treating aging-associated impairments with timp-2 recombinant protei... |
|
|
Invention
|
Methods and compositions for treating pruritus, xerosis, and associated disease using ccr3-inhibi... |
|
|
Invention
|
Methods and compositions for treating retina-associated disease using ccr3-inhibitors. Methods of... |
|
2022
|
Invention
|
Blood plasma fractions for use in liver regeneration. Methods and compositions for treating aging... |
|
|
Invention
|
Blood plasma fractions for use in muscle regeneration. Methods and compositions for treating agin... |
|
|
Invention
|
Methods and compositions for treating aging-associated impairments with trefoil factor family mem... |
|
|
Invention
|
Treatment of aging-associated disease with modulators of leukotriene a4 hydrolase.
Methods and c... |
|
|
Invention
|
Blood plasma fractions as a treatment for aging-associated cognitive disorders.
Methods and comp... |
|
2021
|
Invention
|
Methods of improving retina-associated disease outcome using ccr3-inhibitors.
The disclosure pro... |
|
|
Invention
|
Methods of improving retina-associated disease outcome using ccr3-inhibitors. The disclosure prov... |
|
|
Invention
|
Method of treating liver failure with plasma fraction iv-4. Methods and compositions for treating... |
|
|
Invention
|
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasm... |
|
|
P/S
|
Scientific laboratory services, namely, analysis and testing of blood plasma and blood plasma com... |
|
|
Invention
|
Methods for screening human blood products comprising plasma using immunocompromised rodent model... |
|
2020
|
Invention
|
Blood plasma and plasma fractions as therapy for tumor growth and progression.
The invention rel... |
|
|
Invention
|
Methods of treating a subject for pain. The disclosure pertains to methods of treating pain. In c... |
|
|
Invention
|
Methods of inducing liver regeneration by administering a plasma protein fraction. Provided herei... |
|
|
Invention
|
Use of ccr3-inhibitors.
The present invention relates to CCR3 inhibitors of formula 1,
The pre... |
|
|
Invention
|
4 hydrolase. Methods and compositions for treating and/or preventing aging-related conditions are... |
|
|
Invention
|
Pharmaceutical formulations comprising ccr3 antagonists. The present invention relates to pharmac... |
|
2019
|
Invention
|
Methods of improving or accelerating postoperative recovery. The disclosure pertains to methods f... |
|
2018
|
P/S
|
Pharmaceuticals and medical preparations; pharmaceuticals for the treatment of neurodegenerative ... |
|
2017
|
P/S
|
Pharmaceuticals for the treatment of neurodegenerative diseases and diseases of aging; blood plas... |
|
2015
|
P/S
|
Blood for medical purposes; Blood plasma |
